Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2021 | 1 |
2023 | 2 |
2024 | 2 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Editorial: Synthetic peptide vaccine platforms targeting tumor-specific antigens: advances and challenges.
Front Pharmacol. 2024 Feb 23;15:1363282. doi: 10.3389/fphar.2024.1363282. eCollection 2024.
Front Pharmacol. 2024.
PMID: 38464714
Free PMC article.
No abstract available.
Survivin Expression in Luminal Breast Cancer and Adjacent Normal Tissue for Immuno-Oncology Applications.
Wright S, Burkholz SR, Zelinsky C, Wittman C, Carback RT, Harris PE, Blankenberg T, Herst CV, Rubsamen RM.
Wright S, et al. Among authors: rubsamen rm.
Int J Mol Sci. 2023 Jul 23;24(14):11827. doi: 10.3390/ijms241411827.
Int J Mol Sci. 2023.
PMID: 37511584
Free PMC article.
Item in Clipboard
A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques.
Harris PE, Brasel T, Massey C, Herst CV, Burkholz S, Lloyd P, Blankenberg T, Bey TM, Carback R, Hodge T, Ciotlos S, Wang L, Comer JE, Rubsamen RM.
Harris PE, et al. Among authors: rubsamen rm.
Vaccines (Basel). 2021 May 18;9(5):520. doi: 10.3390/vaccines9050520.
Vaccines (Basel). 2021.
PMID: 34070152
Free PMC article.
Item in Clipboard
Survivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary Study.
Burkholz SR, Herst CV, Carback RT, Harris PE, Rubsamen RM.
Burkholz SR, et al. Among authors: rubsamen rm.
Vaccines (Basel). 2023 Mar 13;11(3):644. doi: 10.3390/vaccines11030644.
Vaccines (Basel). 2023.
PMID: 36992227
Free PMC article.
Item in Clipboard
Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine.
Harris PE, Burkholz S, Herst CV, Rubsamen RM.
Harris PE, et al. Among authors: rubsamen rm.
Vaccines (Basel). 2024 Mar 18;12(3):322. doi: 10.3390/vaccines12030322.
Vaccines (Basel). 2024.
PMID: 38543955
Free PMC article.
Item in Clipboard
An Approach for a Synthetic CTL Vaccine Design against Zika Flavivirus Using Class I and Class II Epitopes Identified by Computer Modeling.
Cunha-Neto E, Rosa DS, Harris PE, Olson T, Morrow A, Ciotlos S, Herst CV, Rubsamen RM.
Cunha-Neto E, et al.
Front Immunol. 2017 Jun 9;8:640. doi: 10.3389/fimmu.2017.00640. eCollection 2017.
Front Immunol. 2017.
PMID: 28649242
Free PMC article.
Item in Clipboard
Cite
Cite